These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 37461166)

  • 1. Botulinum toxin in the treatment of sialorrhea in severe neurological patients with tracheotomy.
    Shao M; Chen K; Wu X; Lin J; Jiang M; Zhuo F; Ying Z; Huang Y
    Brain Behav; 2023 Aug; 13(8):e3164. PubMed ID: 37461166
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Botulinum toxin injections for children with excessive drooling.
    Hassin-Baer S; Scheuer E; Buchman AS; Jacobson I; Ben-Zeev B
    J Child Neurol; 2005 Feb; 20(2):120-3. PubMed ID: 15794177
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Successful treatment of drooling in children with neurological disorders with botulinum toxin A or B.
    Wilken B; Aslami B; Backes H
    Neuropediatrics; 2008 Aug; 39(4):200-4. PubMed ID: 19165707
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of sialorrhea with botulinum toxin A injection in children.
    Ture E; Yazar A; Dundar MA; Bakdik S; Akin F; Pekcan S
    Niger J Clin Pract; 2021 Jun; 24(6):847-852. PubMed ID: 34121732
    [TBL] [Abstract][Full Text] [Related]  

  • 5. BOTOX-A injection of salivary glands for drooling.
    Alvarenga A; Campos M; Dias M; Melão L; Estevão-Costa J
    J Pediatr Surg; 2017 Aug; 52(8):1283-1286. PubMed ID: 28277296
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantitative reduction of saliva production with botulinum toxin type B injection into the salivary glands.
    Turk-Gonzales M; Odderson IR
    Neurorehabil Neural Repair; 2005 Mar; 19(1):58-61. PubMed ID: 15673844
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Up-to-date report of botulinum toxin therapy in patients with drooling caused by different etiologies.
    Ellies M; Laskawi R; Rohrbach-Volland S; Arglebe C
    J Oral Maxillofac Surg; 2003 Apr; 61(4):454-7. PubMed ID: 12684962
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Botulinum toxin A: a new option for treatment of drooling in children with cerebral palsy. Presentation of a case series.
    Jongerius PH; Rotteveel JJ; van den Hoogen F; Joosten F; van Hulst K; Gabreëls FJ
    Eur J Pediatr; 2001 Aug; 160(8):509-12. PubMed ID: 11548191
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effectiveness and safety of botulinum toxin in comparison with surgery for drooling in paediatric patients with neurological disorders: a systematic review.
    Silva JPS; Faria LV; Almeida RC; Medeiros YL; Guimarães LDA
    Br J Oral Maxillofac Surg; 2022 Jun; 60(5):e691-e701. PubMed ID: 35227530
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Botulinum toxin injections for chronic sialorrhoea in children are effective regardless of the degree of neurological dysfunction: A single tertiary institution experience.
    Mahadevan M; Gruber M; Bilish D; Edwards K; Davies-Payne D; van der Meer G
    Int J Pediatr Otorhinolaryngol; 2016 Sep; 88():142-5. PubMed ID: 27497402
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Botulinum toxin in the treatment of drooling in tetraplegic patients with brain injury.
    Ko SH; Shin YB; Min JH; Shin MJ; Chang JH; Shin YI; Ko HY
    Ann Rehabil Med; 2013 Dec; 37(6):796-803. PubMed ID: 24466514
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Botulinum toxin A as a treatment for excessive drooling in children.
    Bothwell JE; Clarke K; Dooley JM; Gordon KE; Anderson R; Wood EP; Camfield CS; Camfield PR
    Pediatr Neurol; 2002 Jul; 27(1):18-22. PubMed ID: 12160968
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intraparotid injection of botulinum toxin A as a treatment to control sialorrhea in children with cerebral palsy.
    Savarese R; Diamond M; Elovic E; Millis SR
    Am J Phys Med Rehabil; 2004 Apr; 83(4):304-11; quiz 312-4, 336. PubMed ID: 15024333
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effectiveness of ultrasound-guided injection of BTX-A in the management of sialorrhea in neurogenic dysphagia patients.
    He Z; Chen S; Zeng P; Dai M; Wei X; Chen J; Zhang X; Dou Z; Wen H; Li C
    Laryngoscope Investig Otolaryngol; 2023 Dec; 8(6):1607-1615. PubMed ID: 38130251
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-lasting benefits of botulinum toxin type B in Parkinson's disease-related drooling.
    Lagalla G; Millevolte M; Capecci M; Provinciali L; Ceravolo MG
    J Neurol; 2009 Apr; 256(4):563-7. PubMed ID: 19401804
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Onabotulinum Toxin A Injections Into the Salivary Glands for Spinal Muscle Atrophy Type I: A Prospective Case Series of 4 Patients.
    Shoval HA; Antelis E; Hillman A; Wei X; Tan P; Alejandro R; Kim H
    Am J Phys Med Rehabil; 2018 Dec; 97(12):873-878. PubMed ID: 30439739
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparing botulinum toxin and 4-duct ligation for Sialorrhea in children - A systematic review.
    Ha TN; Shih MC; Lambert EM
    Am J Otolaryngol; 2024; 45(2):104119. PubMed ID: 38043299
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pediatric Sialorrhea: Submandibular Duct Rerouting and Intraparotid Botulinum Toxin A Injection With Literature Review.
    Calim OF; Hassouna HNH; Yildirim YS; Dogan R; Ozturan O
    Ann Otol Rhinol Laryngol; 2019 Feb; 128(2):104-112. PubMed ID: 30371109
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Factors in the Efficacy, Safety, and Impact on Quality of Life for Treatment of Drooling with Botulinum Toxin Type A in Patients with Cerebral Palsy.
    Gonzalez-L MD; Martinez C; Bori Y Fortuny I; Suso-Vergara S
    Am J Phys Med Rehabil; 2017 Feb; 96(2):68-76. PubMed ID: 28099276
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Botulinum Toxin A for Sialorrhoea Associated with Neurological Disorders: Evaluation of the Relationship between Effect of Treatment and the Number of Glands Treated.
    Restivo DA; Panebianco M; Casabona A; Lanza S; Marchese-Ragona R; Patti F; Masiero S; Biondi A; Quartarone A
    Toxins (Basel); 2018 Jan; 10(2):. PubMed ID: 29382036
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.